Target Group Inc (CBDY)
0.003
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Target Group 1 Year Total Returns (Daily): -5.66% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 07, 2024 | -5.66% |
| May 06, 2024 | 41.51% |
| May 03, 2024 | 36.36% |
| May 02, 2024 | 150.0% |
| May 01, 2024 | 153.3% |
| April 30, 2024 | 133.3% |
| April 29, 2024 | 133.3% |
| April 26, 2024 | 241.2% |
| April 25, 2024 | 57.35% |
| April 24, 2024 | 98.15% |
| April 23, 2024 | 56.76% |
| April 22, 2024 | 21.62% |
| April 19, 2024 | 94.59% |
| April 18, 2024 | 150.9% |
| April 17, 2024 | 124.1% |
| April 16, 2024 | 137.9% |
| April 15, 2024 | 137.9% |
| April 12, 2024 | 43.68% |
| April 11, 2024 | 43.68% |
| April 10, 2024 | 109.1% |
| April 09, 2024 | 69.70% |
| April 08, 2024 | 27.27% |
| April 05, 2024 | 7.74% |
| April 04, 2024 | 18.39% |
| April 03, 2024 | 4.76% |
| Date | Value |
|---|---|
| April 02, 2024 | 17.78% |
| April 01, 2024 | 16.83% |
| March 28, 2024 | 22.22% |
| March 27, 2024 | 22.22% |
| March 26, 2024 | 35.19% |
| March 25, 2024 | 31.11% |
| March 22, 2024 | -24.42% |
| March 21, 2024 | -24.42% |
| March 20, 2024 | -11.63% |
| March 19, 2024 | 26.67% |
| March 18, 2024 | 26.67% |
| March 15, 2024 | 35.53% |
| March 14, 2024 | 35.71% |
| March 13, 2024 | 22.58% |
| March 12, 2024 | 22.58% |
| March 11, 2024 | -12.90% |
| March 08, 2024 | -27.03% |
| March 07, 2024 | -12.90% |
| March 06, 2024 | -0.32% |
| March 05, 2024 | -0.32% |
| March 04, 2024 | -12.90% |
| March 01, 2024 | -10.81% |
| February 29, 2024 | -10.81% |
| February 28, 2024 | -18.92% |
| February 27, 2024 | -34.43% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.84%
Minimum
Apr 22 2020
640.1%
Maximum
May 17 2019
-13.92%
Average
-49.21%
Median
1 Year Total Returns (Daily) Benchmarks
| Acasti Pharma Inc | 5.70% |
| Aurinia Pharmaceuticals Inc | -55.71% |
| Edesa Biotech Inc | -39.08% |
| Lexaria Bioscience Corp | 161.8% |
| Xenon Pharmaceuticals Inc | 2.40% |